BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 17886523)

  • 1. Cost of disorders of the brain in Ireland.
    McHugh JC; Murphy RP; Sobocki P
    Ir Med J; 2007; 100(7):518-21. PubMed ID: 17886523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost estimates of brain disorders in Belgium.
    Schoenen J; Gianni F; Schretlen L; Sobocki P
    Acta Neurol Belg; 2006 Dec; 106(4):208-14. PubMed ID: 17323838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of depression in Europe.
    Sobocki P; Jönsson B; Angst J; Rehnberg C
    J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost of disorders of the brain in Denmark.
    Olesen J; Sobscki P; Truelsen T; Sestoft D; Jönsson B
    Nord J Psychiatry; 2008; 62(2):114-20. PubMed ID: 18569774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost of disorders of the brain in Luxembourg.
    Bisdorff A; Sobocki P; Cloos JM; Andrée C; Graziano ME;
    Bull Soc Sci Med Grand Duche Luxemb; 2006; (3):347-58. PubMed ID: 17209294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating the cost of epilepsy in Europe: a review with economic modeling.
    Pugliatti M; Beghi E; Forsgren L; Ekman M; Sobocki P
    Epilepsia; 2007 Dec; 48(12):2224-33. PubMed ID: 18088267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost of disorders of the brain in Europe 2010.
    Gustavsson A; Svensson M; Jacobi F; Allgulander C; Alonso J; Beghi E; Dodel R; Ekman M; Faravelli C; Fratiglioni L; Gannon B; Jones DH; Jennum P; Jordanova A; Jönsson L; Karampampa K; Knapp M; Kobelt G; Kurth T; Lieb R; Linde M; Ljungcrantz C; Maercker A; Melin B; Moscarelli M; Musayev A; Norwood F; Preisig M; Pugliatti M; Rehm J; Salvador-Carulla L; Schlehofer B; Simon R; Steinhausen HC; Stovner LJ; Vallat JM; Van den Bergh P; van Os J; Vos P; Xu W; Wittchen HU; Jönsson B; Olesen J;
    Eur Neuropsychopharmacol; 2011 Oct; 21(10):718-79. PubMed ID: 21924589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The burden and cost of disorders of the brain in Europe with the inclusion of harmful alcohol use and nicotine addiction.
    Effertz T; Mann K
    Eur Neuropsychopharmacol; 2013 Jul; 23(7):742-8. PubMed ID: 22901735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs of brain disorders in Finland.
    Sillanpää M; Andlin-Sobocki P; Lönnqvist J
    Acta Neurol Scand; 2008 Mar; 117(3):167-72. PubMed ID: 18081913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cost of disorders of the brain in Austria in the year 2004].
    Wancata J; Sobocki P; Katschnig H;
    Wien Klin Wochenschr; 2007; 119(3-4):91-8. PubMed ID: 17347857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of the cost of MS in Europe: extrapolations from a multinational cost study.
    Sobocki P; Pugliatti M; Lauer K; Kobelt G
    Mult Scler; 2007 Sep; 13(8):1054-64. PubMed ID: 17623729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The economic cost of brain disorders in Europe.
    Olesen J; Gustavsson A; Svensson M; Wittchen HU; Jönsson B; ;
    Eur J Neurol; 2012 Jan; 19(1):155-62. PubMed ID: 22175760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The economic impact of overactive bladder syndrome in six Western countries.
    Irwin DE; Mungapen L; Milsom I; Kopp Z; Reeves P; Kelleher C
    BJU Int; 2009 Jan; 103(2):202-9. PubMed ID: 19278532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost of disorders of the brain in Italy.
    Pugliatti M; Sobocki P; Beghi E; Pini S; Cassano GB; Altamura AC; Pozzoli S; Rosati G;
    Neurol Sci; 2008 Apr; 29(2):99-107. PubMed ID: 18483707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost of treating type 2 diabetes (CODEIRE).
    Nolan JJ; O'Halloran D; McKenna TJ; Firth R; Redmond S
    Ir Med J; 2006; 99(10):307-10. PubMed ID: 17274175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspectives in multiple sclerosis health care: special focus on the costs of multiple sclerosis.
    Rotstein Z; Hazan R; Barak Y; Achiron A
    Autoimmun Rev; 2006 Oct; 5(8):511-6. PubMed ID: 17027884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The socioeconomic costs of mental illness in Spain.
    Oliva-Moreno J; López-Bastida J; Montejo-González AL; Osuna-Guerrero R; Duque-González B
    Eur J Health Econ; 2009 Oct; 10(4):361-9. PubMed ID: 19031056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The burden of rheumatoid arthritis and access to treatment: health burden and costs.
    Lundkvist J; Kastäng F; Kobelt G
    Eur J Health Econ; 2008 Jan; 8 Suppl 2():S49-60. PubMed ID: 18157732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost of disorders of the brain in Spain.
    Parés-Badell O; Barbaglia G; Jerinic P; Gustavsson A; Salvador-Carulla L; Alonso J
    PLoS One; 2014; 9(8):e105471. PubMed ID: 25133395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.